XenoPort: Manufacturing Delays Caused Stockout of Horizant – NASDAQ

by admin on April 13, 2013

XenoPort: Manufacturing Delays Caused Stockout of Horizant
NASDAQ
Biopharmaceutical firm XenoPort Inc. ( XNPT ) said GlaxoSmithKline PLC (GSK, GSK.LN) has experienced manufacturing delays that resulted in stockout of Horizant, a restless-leg syndrome drug. Glaxo holds commercialization rights to the drug in the U.S.

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: